Literature DB >> 11255330

Icodextrin cutaneous hypersensitivity: report of 3 psoriasiform cases.

A Valance1, B Lebrun-Vignes, V Descamps, G Queffeulou, B Crickx.   

Abstract

BACKGROUND: Icodextrin is proposed as a new osmotic agent for use in peritoneal dialysis. Because of its recent use, adverse reactions are not well known. Cutaneous adverse effects have been described. We report 3 cases of cutaneous hypersensitivity to icodextrin and discuss the pathogenesis of this reaction. OBSERVATIONS: The cutaneous adverse reaction was psoriasiform in our 3 cases. The eruption was generalized with acute generalized exanthematous pustulosis in 1 case, and limited to the palms and soles in 1 case. It occurred 10 to 15 days after icodextrin therapy was initiated. In patient 1, the results of a rechallenge with icodextrin were positive. Icodextrin therapy was discontinued in all patients.
CONCLUSIONS: Some cases of cutaneous reactions to icodextrin have been reported in the literature, but they are rare. As in our cases, most eruptions are psoriasiform, limited to the palms and soles, or extensive. Although the etiology is unclear, a hypersensitivity reaction, with the formation of immunocomplexes, is probable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255330

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

Review 1.  Icodextrin: a review of its use in peritoneal dialysis.

Authors:  James E Frampton; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Icodextrin-associated hepatotoxicity.

Authors:  Ozkan Gungor; Fatih Kircelli; Erhan Tatar; Huseyin Toz
Journal:  NDT Plus       Date:  2011-08

3.  A case report on allergic rash caused by icodextrin.

Authors:  Şimal Köksal Cevher; Nihal Ozkayar; Fatih Dede
Journal:  Case Rep Nephrol Dial       Date:  2014-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.